Showing results (11-20 of 681) with videos related to
Sort By:
Pageof 69
Hemasphere|September 9, 2020
JAK Inhibition for the Treatment of Myelofibrosis: Limitations and Future PerspectivesPrithviraj Bose, Srdan VerstovsekClinical Lymphoma, Myeloma & Leukemia|July 17, 2021
SOHO State of the Art Updates and Next Questions: Identifying and Treating "Progression" in MyelofibrosisPrithviraj Bose, Srdan VerstovsekExpert Review of Hematology|July 22, 2021
Avapritinib for Systemic MastocytosisPrithviraj Bose, Srdan VerstovsekLeukemia & Lymphoma|April 17, 2020
Management of myelofibrosis after ruxolitinib failurePrithviraj Bose, Srdan VerstovsekCancers|October 14, 2020
Novel Concepts of Treatment for Patients with Myelofibrosis and Related NeoplasmsPrithviraj Bose, Lucia Masarova, Srdan Verstovsek[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 11, 2019
Novel treatment strategies for myeloproliferative neoplasmsPrithviraj Bose, Lucia Masarova, Srdan VerstovsekCurrent Treatment Options in Oncology|January 25, 2019
New Concepts of Treatment for Patients with MyelofibrosisPrithviraj Bose, Mansour Alfayez, Srdan VerstovsekCurrent Hematologic Malignancy Reports|June 23, 2019
The Rationale for Immunotherapy in Myeloproliferative NeoplasmsLucia Masarova, Prithviraj Bose, Srdan VerstovsekExpert Opinion on Pharmacotherapy|April 18, 2023
Cytopenic myelofibrosis: prevalence, relevance, and treatmentPankit Vachhani, Srdan Verstovsek, Prithviraj BoseExpert Opinion on Investigational Drugs|July 23, 2020
Givinostat: an emerging treatment for polycythemia veraHelen T Chifotides, Prithviraj Bose, Srdan VerstovsekPageof 69